Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have worse physical health but similar mental health compared to those without PCOS.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

The guidelines ensure accurate genetic testing and reporting for 21-hydroxylase deficiency.

Eating fewer calories, less sugar and refined carbs, and more low-glycemic and omega-3 rich foods can help manage PCOS symptoms.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Lifestyle changes improve metabolism and fertility in overweight PCOS patients; anti-obesity drugs show potential but need more research.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Quick treatment of hair disorders in teenage girls is important because of the emotional effects.

AI can improve early diagnosis and classification of PCOS, aiding in prevention of related health issues.

PCOS in teens causes hormonal imbalances, irregular periods, and can lead to infertility and other health issues.

Insulin resistance is common in PCOS patients and linked to obesity and increased cardiovascular risk.

Young women with PCOS without additional risk factors may have normal heart function.

The study found a significant link between the renin-angiotensin system and insulin resistance in women with polycystic ovary syndrome.

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

Obese women with PCOS have lower vitamin D levels.

Animal models, especially mice, are essential for advancing hair loss research and treatment.

Letrozole is better for single follicle development and endometrial thickness in PCOS, with no significant difference in pregnancy rates compared to clomiphene.

People with PCOS have higher levels of PAI-1, which may increase their risk of heart disease and fertility issues.

No single treatment effectively cures hirsutism, and evidence for herbal remedies is weak.

Low serum ferritin levels are not closely linked to telogen effluvium in women.

All women with significant unwanted hair growth have hormonal imbalances, often from polycystic ovary syndrome.

Finasteride lowers cortisol and raises testosterone levels in rats.

Understanding hair follicle signaling can improve hair disorder treatments.